Atossa Therapeutics (ATOS) Gross Profit (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Gross Profit of $20384.0 for Q4 2015, up 651.35% year-over-year from $2713.0 in Q4 2014, and down 95.56% quarter-over-quarter from $458838.0 in Q3 2015.
Atossa Therapeutics (ATOS) Gross Profit (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Gross Profit for 5 consecutive years, with $20384.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Gross Profit rose 651.35% year-over-year to $20384.0; the TTM figure through Sep 2016 stood at $20384.0 (down 95.58% YoY), while the FY2015 annual figure was $2.0 million, up 4842.9% from the prior year.
- Gross Profit slipped to $20384.0 in Q4 2015 per ATOS's latest filing, from $458838.0 in the prior quarter.
- Across five years, Gross Profit topped out at $458838.0 in Q3 2015 and bottomed at -$133690.0 in Q4 2013.
- Historically, Gross Profit has averaged $65131.7 across 5 years, with a median of $27709.0 in 2012.
- Annual changes were most pronounced in 2013 — Gross Profit sank 244.22% — and 2015, when it jumped 13292.82%.
- Atossa Therapeutics' Gross Profit stood at -$95690.0 in 2011, then surged by 196.87% to $92696.0 in 2012, then tumbled by 244.22% to -$133690.0 in 2013, then surged by 102.03% to $2713.0 in 2014, then jumped by 651.35% to $20384.0 in 2015.
- Business Quant data shows ATOS's Gross Profit at $20384.0 in Q4 2015, $458838.0 in Q3 2015, and $2713.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 20,384.00 |
| Dec 31, 2015 | 20,384.00 |
| Sep 30, 2015 | 458,838.00 |
| Sep 30, 2015 | 458,838.00 |
| Dec 31, 2014 | 2,713.00 |
| Dec 31, 2014 | 2,713.00 |
| Sep 30, 2014 | 3,426.00 |
| Sep 30, 2014 | 3,426.00 |
| Jun 30, 2014 | 9,875.00 |
| Jun 30, 2014 | 9,875.00 |
| Mar 31, 2014 | 24,124.00 |
| Mar 31, 2014 | 24,124.00 |
| Dec 31, 2013 | -133,690.00 |
| Dec 31, 2013 | -133,690.00 |
| Sep 30, 2013 | 50,659.00 |
| Sep 30, 2013 | 50,659.00 |
| Jun 30, 2013 | 103,918.00 |
| Jun 30, 2013 | 103,918.00 |
| Mar 31, 2013 | 116,206.00 |
| Mar 31, 2013 | 116,206.00 |